1957 & CO. (08495) expects a net loss of approximately HKD 1 million for the first half of the year.

19:39 17/08/2026

1957 & CO. (08495) announced that the Group expects to incur a net loss of approximately HKD 1 million for the six months ending June 30, 2026, compared to a net loss of approximately HKD 2.6 million for the same period in 2025. The Board believes that the anticipated reduction in net loss during the reporting period is primarily due to an increase in the Group's other income, which mainly includes (i) the lifting of a deposit of HKD 2.65 million retained by the Group as a result of the proposed transfer of an unfinished settlement agreement related to the Copperfield Chic restaurant business; and (ii) government subsidies of approximately HKD 235,000 recognized under the technology voucher scheme approved by the Innovation and Technology Commission for the six months ending June 30, 2026.

1957 & CO. (08495) announced that the group expects to incur a net loss of approximately HKD 1 million for the six months ending June 30, 2026, compared to a net loss of approximately HKD 2.6 million for the same period in 2025. The board believes that the anticipated reduction in net loss during the reporting period is primarily due to the increase in the group's other income, which mainly includes (i) the cancellation of the deposit of HKD 2.65 million retained by the group as a result of the uncompleted settlement agreement related to the Causeway Bay Chi no Takumi restaurant business proposal; and (ii) government subsidies of approximately HKD 235,000 recognized under the Technology Voucher Programme approved by the Innovation and Technology Commission for the six months ending June 30, 2026.

CSPC PHARMA (01093): CSPC Innovation Pharmaceutical (300765.SZ) reported a net profit attributable to shareholders of approximately 1.261 billion yuan in the first half of the year, turning losses into profits year-on-year.

HXTL (01085) announces a profit alert, expecting that the net profit attributable to shareholders in the first half of the year will not exceed 10 million yuan.

GAUSH MEDITECH (02407) has signed a five-year exclusive agency agreement with HEIDELBERG for the corneal confocal microscope T3.

HXTL (01085) announces a profit alert, expecting that the net profit attributable to shareholders in the first half of the year will not exceed 10 million yuan.

GAUSH MEDITECH (02407) has signed a five-year exclusive agency agreement with HEIDELBERG for the corneal confocal microscope T3.